GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » EV-to-EBIT

Mountain Valley MD Holdings (FRA:20MP) EV-to-EBIT : -4.08 (As of May. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mountain Valley MD Holdings's Enterprise Value is €8.84 Mil. Mountain Valley MD Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.17 Mil. Therefore, Mountain Valley MD Holdings's EV-to-EBIT for today is -4.08.

The historical rank and industry rank for Mountain Valley MD Holdings's EV-to-EBIT or its related term are showing as below:

FRA:20MP' s EV-to-EBIT Range Over the Past 10 Years
Min: -26.31   Med: 0   Max: 4.36
Current: -4.13

During the past 4 years, the highest EV-to-EBIT of Mountain Valley MD Holdings was 4.36. The lowest was -26.31. And the median was 0.00.

FRA:20MP's EV-to-EBIT is ranked worse than
100% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.955 vs FRA:20MP: -4.13

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Mountain Valley MD Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was €0.59 Mil. Mountain Valley MD Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.17 Mil. Mountain Valley MD Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -369.05%.


Mountain Valley MD Holdings EV-to-EBIT Historical Data

The historical data trend for Mountain Valley MD Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings EV-to-EBIT Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
-0.72 -45.64 -4.39 -1.81

Mountain Valley MD Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.66 -0.10 -1.81 -2.10 -2.00

Competitive Comparison of Mountain Valley MD Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's EV-to-EBIT falls into.



Mountain Valley MD Holdings EV-to-EBIT Calculation

Mountain Valley MD Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8.836/-2.168
=-4.08

Mountain Valley MD Holdings's current Enterprise Value is €8.84 Mil.
Mountain Valley MD Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings  (FRA:20MP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mountain Valley MD Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-2.168/0.587448
=-369.05 %

Mountain Valley MD Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was €0.59 Mil.
Mountain Valley MD Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Valley MD Holdings (FRA:20MP) Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings (FRA:20MP) Headlines

No Headlines